Travel Insurance with Schizophrenia UK 2026: Providers, Screening and Cover

Travel insurance with schizophrenia is obtainable from UK specialist travel insurance providers, though schizophrenia and related psychotic disorders sit at the more complex end of the mental health underwriting spectrum. The episodic nature of the condition, the critical role of medication adherence in maintaining stability, and the potential for acute relapse requiring inpatient treatment abroad all generate more conservative automated screening responses than anxiety or depression. Telephone screening is the appropriate route for most schizophrenia declarations.

How Schizophrenia Is Screened

Schizophrenia and schizoaffective disorder screening addresses several key variables. The date of the most recent inpatient psychiatric admission is the primary underwriting variable: any admission within the previous twelve months generates telephone referral from all automated systems and a more conservative outcome overall. The duration and stability of the current period of remission is assessed through questions about current antipsychotic medication, date of the last prescription change, current community mental health team involvement, and any recent crisis team contacts or A&E attendances for psychiatric reasons.

Current antipsychotic medication is a positive indicator in underwriting terms when stable and consistently taken over an extended period: consistent adherence with no recent dose changes, no recent crisis and stable community mental health follow-up is the most favourable underwriting profile. Depot antipsychotic injections administered on a regular schedule with no missed doses indicate a structured treatment programme that is viewed positively. Recent medication changes, missed doses or gaps in community mental health follow-up generate more conservative underwriting responses.

The destination is relevant for schizophrenia travellers beyond standard considerations. Access to antipsychotic medication at the destination should be confirmed before travel: some antipsychotics available in the UK are not available or are controlled differently in other countries. A sufficient supply for the entire trip plus a substantial safety margin, together with a prescription letter from the treating psychiatrist, is essential preparation. For travellers on depot injections, the timing of the trip around injection schedules is a clinical matter to plan with the treating team before booking.

Which Providers Cover Schizophrenia

GoodToGo and Freedom Insure are the primary recommended providers for schizophrenia and schizoaffective disorder. Both use telephone-based screening that allows a more detailed assessment of psychiatric conditions than automated online questionnaires can provide. For travellers with schizophrenia in stable remission on consistent medication with no recent hospitalisation, both providers can typically generate terms with a loading. InsuranceWith is positioned specifically for conditions that other providers find difficult to accommodate and is a relevant alternative for schizophrenia profiles that have generated adverse outcomes from GoodToGo or Freedom Insure.

iAmInsured is appropriate for travellers with active or recently active schizophrenia, very recent inpatient admission or presentations declined by all other specialist providers. Its telephone-first model and focus on the most complex profiles make it the relevant final option for high-risk psychiatric presentations. Standard and mainstream specialist providers including Staysure, Avanti and InsureandGo may decline schizophrenia declarations at automated screening or apply prohibitive loadings, though the FCA Consumer Duty and ABI mental health commitments prevent blanket psychiatric exclusions without individual assessment.

Clinical and Practical Considerations

Any travel plan for a person with schizophrenia should be discussed with the treating psychiatrist or community mental health team before booking. The team's assessment of travel readiness, the impact of time zone changes on medication schedules and sleep patterns, and the plan for managing any deterioration in an unfamiliar environment are all clinically relevant. A letter from the treating psychiatrist confirming diagnosis, current treatment, stability and fitness to travel is important for both the insurance declaration and any overseas medical consultation. Stress and disrupted sleep are established relapse triggers for schizophrenia. Long-haul travel, jet lag and unfamiliar environments can create conditions that increase relapse risk, and planning to minimise these factors reduces both clinical risk and insurance claim probability.

UK Regulatory Framework for Travel Insurance

All UK travel insurance policies sold to UK residents are regulated by the Financial Conduct Authority under the Insurance Conduct of Business sourcebook, known as ICOBS. ICOBS sets out requirements for product disclosure, fair treatment of customers and the handling of claims and complaints. Any insurer or distributor that breaches ICOBS is subject to FCA enforcement action including financial penalties, public censure and in serious cases prohibition from regulated activities.

The Consumer Duty, which came into force on 31 July 2023 under Policy Statement PS22/9, adds a cross-cutting standard requiring all FCA-regulated firms to deliver good outcomes for retail customers. For travel insurance specifically, the Consumer Duty places obligations on insurers to ensure that products are accessible and fair for customers with characteristics of vulnerability. Older travellers and those with pre-existing medical conditions are explicitly identified in the FCA's guidance as groups that face systematic disadvantage in the standard insurance market and that require particular consideration under the Consumer Duty framework. The four outcome areas of the Consumer Duty are products and services, price and value, consumer understanding, and consumer support. Each area has specific application to the specialist pre-existing conditions travel insurance market.

The Consumer Insurance (Disclosure and Representations) Act 2012 governs the disclosure obligations of all UK travel insurance policyholders. Under this Act, policyholders must take reasonable care not to make a misrepresentation when answering an insurer's screening questions. A deliberate or reckless misrepresentation entitles the insurer to avoid the policy in full and deny all claims regardless of whether the specific claim relates to the undisclosed condition. An inadvertent misrepresentation results in a proportionate remedy: if the insurer would not have written the policy at all, it may avoid but must return the premium; if it would have written at a higher premium, it may reduce the claim proportionately to reflect the premium difference.

The Financial Ombudsman Service is the statutory alternative dispute resolution body for all UK travel insurance complaints. The FOS can award compensation of up to £430,000 per complaint and its decisions are binding on all FCA-regulated firms. Travellers who disagree with any claim decision from any FCA-regulated travel insurer have the right to refer their complaint to the FOS free of charge after the insurer has had eight weeks to respond to the formal complaint. The FOS publishes biannual complaint data covering complaint volumes and uphold rates for named firms, providing an independent public benchmark of claims handling quality across the travel insurance market that is not dependent on provider marketing claims.

The Association of British Insurers publishes guidance on travel insurance best practice, including recommended minimum emergency medical cover limits. The ABI recommends a minimum of £2 million for European travel and at least £5 million for long-haul destinations. For travel to the United States specifically, where private hospital costs can frequently exceed £10,000 per day before surgical intervention or repatriation costs, the ABI guidance points to higher limits of £10 million or more for extended stays. The ABI also notes that cancellation underinsurance is one of the most common causes of partial claim settlements in the travel insurance market, and recommends that travellers ensure their cancellation cover is sufficient to cover the full prepaid cost of their trip including flights, accommodation and pre-booked excursions.

The Global Health Insurance Card, the GHIC, replaced the European Health Insurance Card for UK travellers after the Brexit transition period ended on 31 December 2020. The GHIC provides access to state healthcare in participating European Economic Area countries on the same terms as local residents. It does not cover private treatment, emergency repatriation, trip cancellation, baggage loss, personal liability or any other component of a comprehensive travel insurance policy. The FCA and ABI both advise UK travellers to carry both a valid GHIC and a comprehensive travel insurance policy when travelling in Europe. The two instruments are complementary rather than interchangeable, and holding a GHIC does not reduce the need for travel insurance in any European destination.

How to Compare Specialist Travel Insurance Quotes

When comparing specialist travel insurance quotes for pre-existing medical conditions, the declared condition outcome is the most important variable to establish before comparing premiums. A policy that covers the declared condition with a loading and a policy that covers it with a specific exclusion are not comparable on price alone: the exclusion policy provides no protection for the scenario the traveller is most concerned about, regardless of whether its headline premium is lower. Establishing the specific outcome for each declared condition, whether loading or exclusion, should be the first filter applied to any comparison.

The emergency medical cover limit is the second most important comparison variable for most travellers. The ABI minimum recommendation of £2 million for Europe and £5 million for long-haul destinations represents a floor rather than an adequate ceiling for travellers with serious pre-existing conditions who may require extended inpatient treatment, specialist intervention or medically supervised repatriation. For US-bound travellers in particular, the difference between a £5 million and a £15 million medical limit is material given that inpatient treatment costs in American hospitals can exceed £10,000 per day before specialist fees, surgical costs or repatriation are added.

Cancellation cover is the third key variable for pre-existing condition travellers. The cancellation limit should be sufficient to cover the full prepaid cost of the trip including flights booked directly and through third parties, accommodation prepayments, cruise deposits and any pre-booked tours or experiences. Under-insurance on cancellation is one of the most common causes of partial claim settlements and is often overlooked during the initial purchase decision when the focus is on the medical screening outcome.

The 24-hour emergency assistance helpline is not simply a feature to note but a service whose quality and geographic reach is material to the claim experience. Travellers should confirm before purchase that the assistance line operates around the clock in the destination time zone, that it has direct billing relationships with hospitals in the destination country, and that it has the medical repatriation capability relevant to the planned itinerary. These operational details are confirmed in the policy documentation and by telephoning the assistance line before departure to verify that the contact details are working and that the policy number and cover details are on file.

Frequently Asked Questions

Can I get travel insurance with schizophrenia in the UK?

Yes. UK specialist travel insurance providers can consider schizophrenia through individual screening, typically by telephone. Stable schizophrenia in remission on consistent antipsychotic medication without recent hospitalisation can be placed by GoodToGo, Freedom Insure and InsuranceWith.

Which travel insurer covers schizophrenia?

GoodToGo and Freedom Insure are the primary providers using telephone screening for individual assessment. InsuranceWith is an alternative for complex presentations. iAmInsured is the specialist of last resort for active or recently hospitalised cases.

Do I have to declare schizophrenia for travel insurance?

Yes. Schizophrenia, all related conditions, current medication and any recent inpatient admissions must be declared. The Consumer Insurance (Disclosure and Representations) Act 2012 requires accurate disclosure. Non-declaration allows policy avoidance if deliberate or reckless.

Can I travel abroad with schizophrenia?

Many people with stable schizophrenia travel internationally without incident. Travel readiness should be discussed with the treating psychiatrist. Key considerations include medication supply, prescription documentation, antipsychotic availability at the destination and managing the schedule around any depot injection appointments.